melatonin has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sánchez-Hidalgo, M | 1 |
| Lee, M | 1 |
| de la Lastra, CA | 1 |
| Guerrero, JM | 1 |
| Packham, G | 1 |
1 other study available for melatonin and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Proliferation; Dose-Respons | 2012 |